Completed PHASE4 INTERVENTIONAL 2-arm NCT00549978

Safety and Pharmacokinetics of Probucol and Cilostazol

Phase IV, Safety and Pharmacokinetics of Probucol and Cilostazol When Coadministered in Healthy Subjects

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.

Conditions Healthy

Updated 8 times since 2017 Last updated: Feb 17, 2022 Started: Oct 31, 2007 Primary completion: May 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Healthy and is currently completed. Korea Otsuka Pharmaceutical Co., Ltd. leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Study Description(click to expand)

Safety and Pharmacokinetics of Probucol and Cilostazol when co-administered in Health Subjects

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Completed PHASE4
Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Apr 2022 — Jul 2024 [monthly]

Completed PHASE4

▶ Show 3 earlier versions

Jan 2021 — Apr 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Korea Otsuka Pharmaceutical Co., Ltd.
Otsuka Pharmaceutical Co., Ltd.

Data source: Korea Otsuka Pharmaceutical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea